Overview Atripla to Stribild Switch Study to Evaluate Sleep Disturbances Status: Completed Trial end date: 2016-01-01 Target enrollment: Participant gender: Summary Switch patients from Atripla to Stribild will be evaluated to see if patients have less sleep disturbances. Phase: Phase 4 Details Lead Sponsor: Midtown Medical Center, Tampa, FLCollaborator: Gilead SciencesTreatments: CobicistatEfavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug CombinationElvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug CombinationEmtricitabineEmtricitabine, Tenofovir Disoproxil Fumarate Drug CombinationTenofovir